DARE: Dare Bioscience Inc

DARE新闻

• 12:39 H.C. Wainwright维持Dare Bioscience股票买入评级，尽管拜耳退出合作
• 12:36 Dare Bioscience stock maintains Buy rating at H.C. Wainwright as Bayer exits
• 13:26 Daré Bioscience to regain rights to hormone-free contraceptive from Bayer
• 13:07 Daré Bioscience receives $3.6 million grant payment for contraceptive work
• 12:23 Daré Bioscience, Inc. (DARE) Discusses DARE to PLAY Sildenafil Cream as a Treatment Option for Female Genital Arousal Concerns Transcript
• 22:10 Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
• 22:30 Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Misses Revenue Estimates
• 13:25 Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates
• 23:25 Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
• 22:10 Arcellx, Inc. (ACLX) Reports Q3 Loss, Misses Revenue Estimates
• 13:55 AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates
• 12:29 Daré Bioscience receives $4 million grant installment for contraceptive device
• 14:05 This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Copart (NASDAQ:CPRT), Coherus Oncology (NASDAQ:CHRS)
• 12:43 Maxim Group upgrades Dare Bioscience stock to Buy on funding boost
• 20:46 Dare Bioscience stock price target lowered to $11 at Brookline Capital
• 23:48 Daré Bioscience, Inc. (DARE) Q2 2025 Earnings Call Transcript
• 21:15 Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
• 20:18 Daré Bioscience Posts Narrower Q2 Loss
• 12:15 Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates
• 21:15 Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates
• 12:15 C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates
• 12:15 Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates
• 12:06 Dare Bioscience stock holds Buy rating at H.C. Wainwright on positive trial data
• 17:09 Crude Oil Moves Lower; Daré Bioscience Shares Jump - Diginex (NASDAQ:DGNX), Dare Bioscience (NASDAQ:DARE)